ArticleFrontiers in pharmacology2026
Flurbiprofen in patient-controlled intravenous analgesia and the risk of postoperative nausea and vomiting after gynecologic laparoscopy: a retrospective case-control study.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: To measure the possible association between flurbiprofen-containing patient-controlled intravenous analgesia (PCIA) and an increased risk of postoperative nausea and vomiting (PONV) following gynecological laparoscopic surgery. Methods: The retrospective study was performed on 2,430 patients who underwent a gynecological laparoscopic surgery between April 2021 through May 2022. Perioperative data were extracted from electronic medical records. Multivariable logistic regression was used to identify independent risk factors for PONV, supported by propensity score matching (PSM) and subgroup analyses. A directed acyclic graph (DAG) was constructed to guide confounder selection. Results: Among 2,430 eligible patients, PONV occurred in 27.7% (554/2000) of patients with flurbiprofen-containing PCIA Conclusion: Flurbiprofen-containing PCIA was associated with a modest yet clinically meaningful increase in PONV, especially when combined with hydromorphone. These findings challenge the assumption that NSAIDs are universally protective against PONV and underscore the importance of tailoring multimodal analgesia strategies according to patient risk profiles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.